Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion type Assertion NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_head.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion description "[Dihydropteroate synthase (H2Pte synthase) is the target of the sulfur-based antimalarial drugs, which are frequently used in synergistic combination with inhibitors of dihydrofolate reductase (H2folate reductase) to combat chloroquine-resistant malaria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_provenance.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion evidence source_evidence_literature NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_provenance.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion SIO_000772 7925353 NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_provenance.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion wasDerivedFrom befree-20140225 NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_provenance.
- NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_assertion wasGeneratedBy ECO_0000203 NP279432.RAvsu6-DgZNTj9V6OEGrzqGcQDZG9nZxy3meIZ2-ySs1E130_provenance.